AS Genetic Analysis Company has obtained the Thai Food and Drug Administration’s authorization to test GA-map Dysbiosis in Thailand

Oslo, NorwayJanuary 19, 2023: Molecular Diagnostic Specialist, AS genetic analysis (“GA”) declares that Food and Drug Administration of Thailand (“Thai FDA”) has granted GA authorization for the GA-map® Dysbiosis Test in Thailand. GA has, in association with its distributor Hausen Bernstein Co. Ltd. (“HB”) filed for regulatory approval for the GA-map® Dysbiosis Test in 2022, and we are pleased to announce that the test has now been approved by Thai Food and Drug Administration authorities for clinical use in IBS and IBD patients. HB plans to release a GA-map from its molecular laboratory in Bangkok and to market GA-map® products more widely Thailand.

Ronnie HermansenExecutive Director of Genetic Analysis, comments:
“GA is proud to announce that the GA-map Dysbiosis Test has been approved by the Thai Food and Drug Administration authorities. Regulatory approval will enable the physician/specialist to use the Dysbiosis test for clinical diagnostic use in patients with IBS and IBD.” GA Map® The Hausen Bernstein platform will enable the provision of the highest quality microbiome tests in the world Thailand“.

The market demand for gut microbiome assessments is rapidly increasing globally in private healthcare services, clinical practice, and academic research with a focus on patient identification and classification of microbiota. Together with HB, GA can now offer this FDA approved modular gut microbiome test platform to the Thai market to meet the growing interest and increased awareness of dysbacteriosis.

Dr. Banlang Luangwaranan, CEO of Hausen Bernstein, comments:
“HB is pleased to announce that the GA-map Dysbiosis Test has received authorization from the Thai Food and Drug Administration and that the GA-map Dysbiosis Test will now be available for clinical diagnostic use. We see that the focus on the balance of our microbiome is increasing rapidly as more and more people experience related issues. “The GA-map will be a great complement to our growing food allergy testing business. HB’s core value is to provide high quality products to our customers, and we are proud to add GA-map to our high-end product portfolio.”

For more information, please contact:Ronnie HermansenExecutive Director
Email: rh@genetic-analysis.com

About Hausen Bernstein Co. Ltd.:
Established in 2003, Hausen Bernstein Co. is a rapidly growing medical technology company primarily focused on providing the highest level of products, services and technical support to the Thai healthcare system. Hausen Bernstein also distributes products from more than 20 well-known suppliers Europewe, JapanAnd SingaporeAnd China.

On the diagnostic (IVD) side, products cover areas within autoimmune diseases, allergy diagnostic tests, point-of-care testing for respiratory infections, gastrointestinal diseases, testing for food intolerances, and vector-borne diseases. As well as molecular diagnostic tests for infectious diseases and cancer diagnosis. Other than IVD products, Hausen Bernstein provides unique medical devices to the health and wellness sector.

Hausen Bernstein products are positioned as the highest standard in every field, and our customers are the highest ranked healthcare units in ThailandAnd medical schools, famous private hospitals, hospital chains and private laboratories. The sales team covers the whole territory Thailand.

for more information: https://www.hausen.co.th/

About genetic analysis:
AS genetic analysis (GA) is a science-based diagnostics company and leader in the human microbiome field with over 10 years of experience in research and product development. The unique GA-map® platform is based on a predefined multiplex targets approach specialized for the simultaneous analysis of a large number of bacteria in a single reaction. Test results are generated through the use of a sophisticated, clinically validated GA-map® software algorithm. This enables immediate results without the need for further bioinformatics work. GA’s vision is to become the leading manufacturer of standardized tests for the gut microbiome worldwide, and GA is committed to helping unlock and restore the human microbiome through its state-of-the-art technology. GA employs a team of highly qualified personnel with scientific backgrounds and proficiency in Bioinformatics, Molecular Biology and Bioengineering. www.genetic-analysis.com

Interested in reading more about GA products? Please visit ga-map.com

https://news.cision.com/genetic-analysis-as/r/genetic-analysis-as-achieves-thai-fda-license-for-ga-map–dysbiosis-test-in-thailand,c3699927

https://mb.cision.com/Main/20846/3699927/1790651.pdf

(C) 2023 Cision. all rights are save. , Source Press releases – English

Leave a Comment